Paper20032295
A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties.
Navarro-Xavier RA and 5 others. J Immunol, 2010. Cited by 84 papers, by iCite.
Cite this record
ConductScience Library. A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties. Papers, record 20032295. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20032295
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Delivery Systems | Major topic |
| Inflammation Mediators | Major topic |
| Animals | |
| Cell Movement | |
| Cells, Cultured | |
| Homeostasis | |
| Injections, Intraperitoneal | |
| Lymphocytes | |
| Macrophages | |
| Mice | |
| Mice, Inbred C57BL | |
| Neutrophils | |
| Peritonitis | |
| Zymosan |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 087520 | Wellcome Trust | United Kingdom | PubMed | |
| Medical Research Council | United Kingdom | PubMed |
Source PubMed
Cited by55
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40977737 | Inhibition of IL-27 signaling regulates chemokine levels and sustains CXCR2 receptor expression on mononuclear cells to improve disease outcomes during gram-negative neonatal sepsis. | Front Immunol | 2025 | https://conductscience.org/library/papers/40977737 | PubMed |
| 39713922 | Review of methodology and re-analysis of lipidomic data focusing on specialised pro-resolution lipid mediators (SPMs) in a human model of resolving inflammation. | Int J Exp Pathol | 2025 | https://conductscience.org/library/papers/39713922 | PubMed |
| 39242914 | Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution. | Nat Metab | 2024 | https://conductscience.org/library/papers/39242914 | PubMed |
| 38533160 | Comparative Study of Azithromycin Versus Doxycycline Effect on the Resistin Level in Periodontitis Patients With Type 2 Diabetes: A Randomized Controlled Clinical Trial. | Cureus | 2024 | https://conductscience.org/library/papers/38533160 | PubMed |
| 37879110 | Stereoselective Synthesis, Pro-resolution, and Anti-inflammatory Actions of RvD5n-3 DPA. | J Nat Prod | 2023 | https://conductscience.org/library/papers/37879110 | PubMed |
| 37446699 | Specialized Pro-Resolving Lipid Mediators: Endogenous Roles and Pharmacological Activities in Infections. | Molecules | 2023 | https://conductscience.org/library/papers/37446699 | PubMed |
| 34897650 | Bruton's TK regulates myeloid cell recruitment during acute inflammation. | Br J Pharmacol | 2022 | https://conductscience.org/library/papers/34897650 | PubMed |
| 33995086 | Biochanin A Regulates Key Steps of Inflammation Resolution in a Model of Antigen-Induced Arthritis via GPR30/PKA-Dependent Mechanism. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/33995086 | PubMed |
| 33708206 | Untangling Local Pro-Inflammatory, Reparative, and Regulatory Damage-Associated Molecular-Patterns (DAMPs) Pathways to Improve Transplant Outcomes. | Front Immunol | 2021 | https://conductscience.org/library/papers/33708206 | PubMed |
| 32757380 | MCTR1 enhances the resolution of lipopolysaccharide-induced lung injury through STAT6-mediated resident M2 alveolar macrophage polarization in mice. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/32757380 | PubMed |
| 32265698 | A Pro-resolving Role for Galectin-1 in Acute Inflammation. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32265698 | PubMed |
| 32251403 | Blocking elevated p38 MAPK restores efferocytosis and inflammatory resolution in the elderly. | Nat Immunol | 2020 | https://conductscience.org/library/papers/32251403 | PubMed |
| 31613219 | Inhibition of ErbB kinase signalling promotes resolution of neutrophilic inflammation. | Elife | 2019 | https://conductscience.org/library/papers/31613219 | PubMed |
| 31156629 | Myeloid Cell and Transcriptome Signatures Associated With Inflammation Resolution in a Model of Self-Limiting Acute Brain Inflammation. | Front Immunol | 2019 | https://conductscience.org/library/papers/31156629 | PubMed |
| 31001110 | Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31001110 | PubMed |
| 29729109 | Stroma: the forgotten cells of innate immune memory. | Clin Exp Immunol | 2018 | https://conductscience.org/library/papers/29729109 | PubMed |
| 29588627 | Zymosan attenuates melanoma growth progression, increases splenocyte proliferation and induces TLR-2/4 and TNF-α expression in mice. | J Inflamm (Lond) | 2018 | https://conductscience.org/library/papers/29588627 | PubMed |
| 28802833 | New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration. | Mol Aspects Med | 2018 | https://conductscience.org/library/papers/28802833 | PubMed |
| 28336292 | Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors. | Mol Aspects Med | 2017 | https://conductscience.org/library/papers/28336292 | PubMed |
| 28263773 | Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology. | Mol Aspects Med | 2017 | https://conductscience.org/library/papers/28263773 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20032295
GET https://conductscience.org/api/papers/v1/20032295/cited_by?page=2